PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 47 filers reported holding PROQR THRAPEUTICS N V in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,711 | -45.8% | 6,701 | -32.5% | 0.00% | – |
| Q2 2023 | $16,082 | +1394.6% | 9,927 | +1865.7% | 0.00% | – |
| Q1 2023 | $1,076 | -86.8% | 505 | -77.1% | 0.00% | – |
| Q4 2022 | $8,158 | -76.0% | 2,205 | +4693.5% | 0.00% | – |
| Q3 2022 | $34,000 | -98.5% | 46 | -98.5% | 0.00% | – |
| Q2 2022 | $2,344,000 | -87.4% | 3,014 | +29.6% | 0.00% | – |
| Q4 2021 | $18,631,000 | +787.2% | 2,326 | +365.2% | 0.00% | – |
| Q4 2020 | $2,100,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |